Synthesis and trypanocidal activity of novel pyridinyl-1,3,4-thiadiazole derivatives. 2020

Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
Laboratório de Avaliação e Síntese de Substâncias Bioativas (LASSBio), Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, 21941902, Rio de Janeiro, RJ, Brazil.

Herein, we present the design, synthesis and trypanocidal evaluation of sixteen new 1,3,4-thiadiazole derivatives from N-aminobenzyl or N-arylhydrazone series. All derivatives were assayed against the trypomastigote form of Trypanosoma cruzi, showing IC50 values ranging from 3 to 226 μM, and a better trypanocidal profile was demonstrated for the 1,3,4-thiadiazole-N-arylhydrazones (3a-g). In this series, the 2-pyridinyl fragment bound to the imine subunit of the hydrazine moiety presented pharmacophoric behavior for trypanocidal activity. Compounds 2a, 11a and 3e presented remarkable activity and excellent selectivity indexes. Compound 2a was also active against the intracellular amastigote form of T. cruzi. Moreover, its corresponding hydrochloride, compound 11a, showed the most promising profile, producing phenotypic changes similar to those caused by posaconazole, a well-known inhibitor of sterol biosynthesis. Thus, 1,3,4-thiadiazole derivative 11a could be considered a good prototype for the development of new drug candidates for Chagas disease therapy.

UI MeSH Term Description Entries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
February 1989, Farmaco (Societa chimica italiana : 1989),
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
January 2021, Frontiers in chemistry,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
May 2024, Journal of agricultural and food chemistry,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
January 2022, Frontiers in chemistry,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
April 2008, Bioorganic & medicinal chemistry,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
December 2012, Molecules (Basel, Switzerland),
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
May 2024, Chemistry & biodiversity,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
July 1970, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
January 2022, Frontiers in chemistry,
Rosana H C N Freitas, and Juliana M C Barbosa, and Patrícia Bernardino, and Vitor Sueth-Santiago, and Solange M S V Wardell, and James L Wardell, and Débora Decoté-Ricardo, and Tatiana G Melo, and Edson F da Silva, and Kelly Salomão, and Carlos A M Fraga
August 2012, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!